SPY322.43-8.22 -2.49%
DIA267.96-8.56 -3.10%
IXIC10,606.66-186.63 -1.73%

Wedbush Initiates Coverage On IVERIC bio with Outperform Rating, Announces $13 Price Target

Wedbush analyst David Nierengarten initiates coverage on IVERIC bio (NASDAQ:ISEE) with a Outperform rating and a $13 price target.

Benzinga · 01/07/2020 13:17

Wedbush analyst David Nierengarten initiates coverage on IVERIC bio (NASDAQ:ISEE) with a Outperform rating and a $13 price target.